Report Detail
Global Radiosensitizer Market Growth (Status and Outlook) 2022-2028
- RnM4462917 |
- 11 July, 2022 |
- Global |
- 100 Pages |
- LPI(LP Information) |
- Service & Software
As the global economy mends, the 2021 growth of Radiosensitizer will have significant change from previous year. According to our (LP Information) latest study, the global Radiosensitizer market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Radiosensitizer market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Radiosensitizer market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Radiosensitizer market, reaching US$ million by the year 2028. As for the Europe Radiosensitizer landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Radiosensitizer players cover KORTUC, Debiopharm, Kunyao Group, and Shandong Xinhua Pharmaceutical Co., Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiosensitizer market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
DNA Precursor Base Analogs
Electrophilic Radiosensitizer
Bioreductive Compounds
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Leukemia
Rectal Cancer
Head and Neck Cancer
Breast Cancer
Lung Cancer
Esophageal Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
KORTUC
Debiopharm
Kunyao Group
Shandong Xinhua Pharmaceutical Co., Ltd.
Nanobiotix
Merck KGaA
Eli Lilly
Celgene
Roche Genentech
Astellas
EpcentRx/ SciClone
MT3
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Radiosensitizer Market Size 2017-2028
- 2.1.2 Radiosensitizer Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Radiosensitizer Segment by Type
- 2.2.1 DNA Precursor Base Analogs
- 2.2.2 Electrophilic Radiosensitizer
- 2.2.3 Bioreductive Compounds
- 2.2.4 Others
- 2.3 Radiosensitizer Market Size by Type
- 2.3.1 Radiosensitizer Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Radiosensitizer Market Size Market Share by Type (2017-2022)
- 2.4 Radiosensitizer Segment by Application
- 2.4.1 Leukemia
- 2.4.2 Rectal Cancer
- 2.4.3 Head and Neck Cancer
- 2.4.4 Breast Cancer
- 2.4.5 Lung Cancer
- 2.4.6 Esophageal Cancer
- 2.4.7 Others
- 2.5 Radiosensitizer Market Size by Application
- 2.5.1 Radiosensitizer Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Radiosensitizer Market Size Market Share by Application (2017-2022)
3 Radiosensitizer Market Size by Player
- 3.1 Radiosensitizer Market Size Market Share by Players
- 3.1.1 Global Radiosensitizer Revenue by Players (2020-2022)
- 3.1.2 Global Radiosensitizer Revenue Market Share by Players (2020-2022)
- 3.2 Global Radiosensitizer Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Radiosensitizer by Regions
- 4.1 Radiosensitizer Market Size by Regions (2017-2022)
- 4.2 Americas Radiosensitizer Market Size Growth (2017-2022)
- 4.3 APAC Radiosensitizer Market Size Growth (2017-2022)
- 4.4 Europe Radiosensitizer Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Radiosensitizer Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Radiosensitizer Market Size by Country (2017-2022)
- 5.2 Americas Radiosensitizer Market Size by Type (2017-2022)
- 5.3 Americas Radiosensitizer Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Radiosensitizer Market Size by Region (2017-2022)
- 6.2 APAC Radiosensitizer Market Size by Type (2017-2022)
- 6.3 APAC Radiosensitizer Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Radiosensitizer by Country (2017-2022)
- 7.2 Europe Radiosensitizer Market Size by Type (2017-2022)
- 7.3 Europe Radiosensitizer Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Radiosensitizer by Region (2017-2022)
- 8.2 Middle East & Africa Radiosensitizer Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Radiosensitizer Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Radiosensitizer Market Forecast
- 10.1 Global Radiosensitizer Forecast by Regions (2023-2028)
- 10.1.1 Global Radiosensitizer Forecast by Regions (2023-2028)
- 10.1.2 Americas Radiosensitizer Forecast
- 10.1.3 APAC Radiosensitizer Forecast
- 10.1.4 Europe Radiosensitizer Forecast
- 10.1.5 Middle East & Africa Radiosensitizer Forecast
- 10.2 Americas Radiosensitizer Forecast by Country (2023-2028)
- 10.2.1 United States Radiosensitizer Market Forecast
- 10.2.2 Canada Radiosensitizer Market Forecast
- 10.2.3 Mexico Radiosensitizer Market Forecast
- 10.2.4 Brazil Radiosensitizer Market Forecast
- 10.3 APAC Radiosensitizer Forecast by Region (2023-2028)
- 10.3.1 China Radiosensitizer Market Forecast
- 10.3.2 Japan Radiosensitizer Market Forecast
- 10.3.3 Korea Radiosensitizer Market Forecast
- 10.3.4 Southeast Asia Radiosensitizer Market Forecast
- 10.3.5 India Radiosensitizer Market Forecast
- 10.3.6 Australia Radiosensitizer Market Forecast
- 10.4 Europe Radiosensitizer Forecast by Country (2023-2028)
- 10.4.1 Germany Radiosensitizer Market Forecast
- 10.4.2 France Radiosensitizer Market Forecast
- 10.4.3 UK Radiosensitizer Market Forecast
- 10.4.4 Italy Radiosensitizer Market Forecast
- 10.4.5 Russia Radiosensitizer Market Forecast
- 10.5 Middle East & Africa Radiosensitizer Forecast by Region (2023-2028)
- 10.5.1 Egypt Radiosensitizer Market Forecast
- 10.5.2 South Africa Radiosensitizer Market Forecast
- 10.5.3 Israel Radiosensitizer Market Forecast
- 10.5.4 Turkey Radiosensitizer Market Forecast
- 10.5.5 GCC Countries Radiosensitizer Market Forecast
- 10.6 Global Radiosensitizer Forecast by Type (2023-2028)
- 10.7 Global Radiosensitizer Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 KORTUC
- 11.1.1 KORTUC Company Information
- 11.1.2 KORTUC Radiosensitizer Product Offered
- 11.1.3 KORTUC Radiosensitizer Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 KORTUC Main Business Overview
- 11.1.5 KORTUC Latest Developments
- 11.2 Debiopharm
- 11.2.1 Debiopharm Company Information
- 11.2.2 Debiopharm Radiosensitizer Product Offered
- 11.2.3 Debiopharm Radiosensitizer Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Debiopharm Main Business Overview
- 11.2.5 Debiopharm Latest Developments
- 11.3 Kunyao Group
- 11.3.1 Kunyao Group Company Information
- 11.3.2 Kunyao Group Radiosensitizer Product Offered
- 11.3.3 Kunyao Group Radiosensitizer Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Kunyao Group Main Business Overview
- 11.3.5 Kunyao Group Latest Developments
- 11.4 Shandong Xinhua Pharmaceutical Co., Ltd.
- 11.4.1 Shandong Xinhua Pharmaceutical Co., Ltd. Company Information
- 11.4.2 Shandong Xinhua Pharmaceutical Co., Ltd. Radiosensitizer Product Offered
- 11.4.3 Shandong Xinhua Pharmaceutical Co., Ltd. Radiosensitizer Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Shandong Xinhua Pharmaceutical Co., Ltd. Main Business Overview
- 11.4.5 Shandong Xinhua Pharmaceutical Co., Ltd. Latest Developments
- 11.5 Nanobiotix
- 11.5.1 Nanobiotix Company Information
- 11.5.2 Nanobiotix Radiosensitizer Product Offered
- 11.5.3 Nanobiotix Radiosensitizer Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Nanobiotix Main Business Overview
- 11.5.5 Nanobiotix Latest Developments
- 11.6 Merck KGaA
- 11.6.1 Merck KGaA Company Information
- 11.6.2 Merck KGaA Radiosensitizer Product Offered
- 11.6.3 Merck KGaA Radiosensitizer Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Merck KGaA Main Business Overview
- 11.6.5 Merck KGaA Latest Developments
- 11.7 Eli Lilly
- 11.7.1 Eli Lilly Company Information
- 11.7.2 Eli Lilly Radiosensitizer Product Offered
- 11.7.3 Eli Lilly Radiosensitizer Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Eli Lilly Main Business Overview
- 11.7.5 Eli Lilly Latest Developments
- 11.8 Celgene
- 11.8.1 Celgene Company Information
- 11.8.2 Celgene Radiosensitizer Product Offered
- 11.8.3 Celgene Radiosensitizer Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Celgene Main Business Overview
- 11.8.5 Celgene Latest Developments
- 11.9 Roche Genentech
- 11.9.1 Roche Genentech Company Information
- 11.9.2 Roche Genentech Radiosensitizer Product Offered
- 11.9.3 Roche Genentech Radiosensitizer Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Roche Genentech Main Business Overview
- 11.9.5 Roche Genentech Latest Developments
- 11.10 Astellas
- 11.10.1 Astellas Company Information
- 11.10.2 Astellas Radiosensitizer Product Offered
- 11.10.3 Astellas Radiosensitizer Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Astellas Main Business Overview
- 11.10.5 Astellas Latest Developments
- 11.11 EpcentRx/ SciClone
- 11.11.1 EpcentRx/ SciClone Company Information
- 11.11.2 EpcentRx/ SciClone Radiosensitizer Product Offered
- 11.11.3 EpcentRx/ SciClone Radiosensitizer Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 EpcentRx/ SciClone Main Business Overview
- 11.11.5 EpcentRx/ SciClone Latest Developments
- 11.12 MT3
- 11.12.1 MT3 Company Information
- 11.12.2 MT3 Radiosensitizer Product Offered
- 11.12.3 MT3 Radiosensitizer Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 MT3 Main Business Overview
- 11.12.5 MT3 Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Radiosensitizer. Industry analysis & Market Report on Radiosensitizer is a syndicated market report, published as Global Radiosensitizer Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Radiosensitizer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
